Key result
Carvedilol lowered plasma noradrenaline and blood viscosity compared to atenolol in men with recent myocardial infarction.
Why the study?
Does carvedilol reduce plasma noradrenaline and blood viscosity compared to atenolol in men with recent myocardial infarction?
RCT (n=20)
Randomized
Does carvedilol reduce plasma noradrenaline and blood viscosity compared to atenolol in men with recent myocardial infarction?
Carvedilol provides stronger inhibition of the sympathetic nervous system and reduces blood viscosity more effectively than atenolol in post-myocardial infarction patients.
Answers are grounded in this paper and cite their sources.
May support carvedilol over atenolol post-MI; extends RCT evidence of non-equivalent beta-blocker effects.
The Carvedilol Acute Myocardial Infarction Study (CAMIS) investigates cardiac remodeling in patients (n = 250) randomized to carvedilol vs atenolol and treated for 12 months after acute myocardial infarction. In a sub-study, we compared sympathetic, hemorrheological and vascular effects in small but particularly well-matched groups of participants who had been on reasonably equipotent but unchanged doses of carvedilol (n = 10) or atenolol (n = 10) for at least 4 weeks. Blood pressures (p < 0.05), plasma adrenaline (p = 0.034), plasma vasopressin (p = 0.022) and whole blood viscosity at shear rate 0.5 cp (p = 0.050), 1.1 cp (p = 0.023), 5.8 cp (p = 0.049) and 201 cp (p = 0.060) taken in the laboratory at baseline before 2 h of using the hyperinsulinemic, isoglycemic glucose clamp were lower on carvedilol. Plasma noradrenaline was lower on carvedilol at baseline and throughout the clamp (p < 0.0005). Forearm vascular resistance as measured by plethysmography during the clamp tended to be lower on carvedilol (p = 0.074). No significant difference was found between the groups in glucose disposal rate measured by clamp, maximal forearm blood flow and minimal forearm vascular resistance after 10 min of ischemia, or in ambulatory blood pressure and heart rate taken a few days later. Thus, potential benefits of carvedilol vs atenolol were seen in these post-infarction patients in a laboratory setting. These findings suggest that the inhibitory effects on the sympathetic nervous system and related blood viscosity are stronger with carvedilol than with atenolol.
No takes yet. Share an insight, caveat, or question.
Jónsson et al. (2002) conducted an RCT in Recent myocardial infarction (n=20). Carvedilol vs. Atenolol was evaluated on Sympathetic, hemorrheological and vascular effects (including plasma noradrenaline and blood viscosity) (p=<0.0005). Carvedilol lowered plasma noradrenaline and blood viscosity compared to atenolol in men with recent myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: